{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:38:01Z","timestamp":1787225881484,"version":"build-2736575974"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-11047-4","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T14:05:44Z","timestamp":1758549944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Modulation of NF-\u03baB pathway in cancer therapy by sodium butyrate and Isoproterenol"],"prefix":"10.1007","volume":"52","author":[{"given":"Khushboo","family":"Singhal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Malya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helianthous","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brij","family":"Bharti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"key":"11047_CR1","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2025.108564","volume":"119","author":"PB Vimala","year":"2025","unstructured":"Vimala PB, Vajravelu LK, Lathakumari RH et al (2025) Targeting cadherins with colicins: molecular docking and dynamics reveal disruptive potential in cancer metastasis. Comput Biol Chem 119:108564","journal-title":"Comput Biol Chem"},{"key":"11047_CR2","volume":"10","author":"Y Li","year":"2025","unstructured":"Li Y, Liu F, Cai Q et al (2025) Invasion and metastasis in cancer: molecular insights and therapeutic targets. Signal Transduct Target Ther 10:57","journal-title":"Signal Transduct Target Ther"},{"key":"11047_CR3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2174\/0115680096289260240311062343","volume":"25","author":"A Debnath","year":"2025","unstructured":"Debnath A, Mazumder R (2025) Clinical progress of targeted therapy for breast cancer: a comprehensive review. Curr Cancer Drug Targets 25:555\u2013573","journal-title":"Curr Cancer Drug Targets"},{"key":"11047_CR4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-019-0268-3","volume":"17","author":"DY Oh","year":"2020","unstructured":"Oh DY, Bang YJ (2020) HER2-targeted therapies-a role beyond breast cancer. Nat Rev Clin Oncol 17:33\u201348","journal-title":"Nat Rev Clin Oncol"},{"key":"11047_CR5","doi-asserted-by":"crossref","first-page":"9564","DOI":"10.1200\/JCO.2021.39.15_suppl.9564","volume":"39","author":"N Jackson","year":"2021","unstructured":"Jackson N, Rodgers T, John I et al (2021) Outcomes of BRAF mutant metastatic melanoma (MM) patients (pts) after cessation of targeted therapy (TT) with BRAF or BRAF\/MEK inhibitor(i). J Clin Oncol 39:9564\u20139564","journal-title":"J Clin Oncol"},{"key":"11047_CR6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.yexcr.2014.01.024","volume":"324","author":"SN Saldanha","year":"2014","unstructured":"Saldanha SN, Kala R, Tollefsbol TO (2014) Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating Epigallocatechin gallate and sodium butyrate. Exp Cell Res 324:40\u201353","journal-title":"Exp Cell Res"},{"key":"11047_CR7","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","volume":"22","author":"H Mao","year":"2025","unstructured":"Mao H, Zhao X, Sun S-C (2025) NF-\u03baB in inflammation and cancer. Cell Mol Immunol 22:811\u2013839","journal-title":"Cell Mol Immunol"},{"key":"11047_CR8","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.156044","volume":"272","author":"T Aanniz","year":"2025","unstructured":"Aanniz T, Bakrim S, Amanullah M, Bouyahya A (2025) Nuclear receptors in cancer: unveiling theranostic potentials and innovative therapeutic strategies. Pathol Res Pract 272:156044","journal-title":"Pathol Res Pract"},{"key":"11047_CR9","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2009.10.014","volume":"139","author":"D Iliopoulos","year":"2009","unstructured":"Iliopoulos D, Hirsch HA, Struhl K (2009) An epigenetic switch involving NF-kappaB, Lin28, Let-7 microRNA, and IL6 links inflammation to cell transformation. Cell 139:693\u2013706","journal-title":"Cell"},{"key":"11047_CR10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.intimp.2010.12.006","volume":"11","author":"VR Yadav","year":"2011","unstructured":"Yadav VR, Prasad S, Sung B, Aggarwal BB (2011) The role of Chalcones in suppression of NF-\u03baB-mediated inflammation and cancer. Int Immunopharmacol 11:295\u2013309","journal-title":"Int Immunopharmacol"},{"key":"11047_CR11","doi-asserted-by":"crossref","first-page":"1417502","DOI":"10.3389\/fcell.2024.1417502","volume":"12","author":"X Sun","year":"2024","unstructured":"Sun X, Cao S, Mao C et al (2024) Post-translational modifications of p65: state of the art. Front Cell Dev Biol 12:1417502","journal-title":"Front Cell Dev Biol"},{"key":"11047_CR12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev-biophys-083012-130338","volume":"42","author":"J Napetschnig","year":"2013","unstructured":"Napetschnig J, Wu H (2013) Molecular basis of NF-\u03baB signaling. Annu Rev Biophys 42:443\u2013468","journal-title":"Annu Rev Biophys"},{"key":"11047_CR13","doi-asserted-by":"crossref","first-page":"55233","DOI":"10.12775\/QS.2024.27.55233","volume":"27","author":"M G\u0142\u0105bie\u0144","year":"2024","unstructured":"G\u0142\u0105bie\u0144 M, Mi\u0142kowski P, Ku\u015bnierz A et al (2024) Sodium butyrate as gut microbiota modulators: mechanisms of action and potential clinical applications-literature review and new perspectives. Qual Sport 27:55233\u201355233","journal-title":"Qual Sport"},{"key":"11047_CR14","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.bcp.2004.05.039","volume":"68","author":"V Quivy","year":"2004","unstructured":"Quivy V, Van Lint C (2004) Regulation at multiple levels of NF-\u03baB-mediated transactivation by protein acetylation. Biochem Pharmacol 68:1221\u20131229","journal-title":"Biochem Pharmacol"},{"key":"11047_CR15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s13287-023-03571-6","volume":"14","author":"R Farahzadi","year":"2023","unstructured":"Farahzadi R, Valipour B, Fathi E et al (2023) Oxidative stress regulation and related metabolic pathways in epithelial-mesenchymal transition of breast cancer stem cells. Stem Cell Res Ther 14:342","journal-title":"Stem Cell Res Ther"},{"key":"11047_CR16","unstructured":"Cameron RB (2018) Elucidation of the Mechanism of Beta-2 Adrenergic Receptor Agonist-Mediated Mitochondrial Biogenesis [dissertation]. Medical University of South Carolina"},{"key":"11047_CR17","doi-asserted-by":"crossref","first-page":"1394557","DOI":"10.3389\/fphar.2024.1394557","volume":"15","author":"N Anajirih","year":"2024","unstructured":"Anajirih N, Abdeen A, Tahar ES et al (2024) Alchemilla vulgaris modulates isoproterenol-induced biochemical, histopathological, and molecular changes in cardiac tissue: a systems biology approach. Front Pharmacol 15:1394557","journal-title":"Front Pharmacol"},{"issue":"1","key":"11047_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12291-013-0401-5","volume":"30","author":"SK Shukla","year":"2015","unstructured":"Shukla SK, Sharma SB, Singh UR (2015) \u03b2-Adrenoreceptor agonist isoproterenol alters oxidative status, inflammatory signaling, injury markers and apoptotic cell death in myocardium of rats. Indian J Clin Biochem 30(1):27\u201334. https:\/\/doi.org\/10.1007\/s12291-013-0401-5","journal-title":"Indian J Clin Biochem"},{"key":"11047_CR19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fcvm.2019.00068","volume":"6","author":"G Shanmugam","year":"2019","unstructured":"Shanmugam G, Challa AK, Devarajan A et al (2019) Exercise mediated Nrf2 signaling protects the myocardium from isoproterenol-induced pathological remodeling. Front Cardiovasc Med 6:68","journal-title":"Front Cardiovasc Med"},{"key":"11047_CR20","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2174\/1573401316999201029210912","volume":"17","author":"D Singh","year":"2021","unstructured":"Singh D, Gupta S (2021) Butyrate: a review on beneficial pharmacological and therapeutic effect. Curr Nutr Food Sci 17:470\u2013482","journal-title":"Curr Nutr Food Sci"},{"key":"11047_CR21","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1111\/cas.14532","volume":"111","author":"S Blondy","year":"2020","unstructured":"Blondy S, David V, Verdier M et al (2020) 5-fluorouracil resistance mechanisms in colorectal cancer: from classical pathways to promising processes. Cancer Sci 111:3142\u20133154","journal-title":"Cancer Sci"},{"key":"11047_CR22","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2174\/1871527316666170725114652","volume":"16","author":"G Marwarha","year":"2017","unstructured":"Marwarha G, Ghribi O (2017) Nuclear factor Kappa-light-chain-enhancer of activated B cells (NF-\u039aB)-a friend, a foe, or a bystander-in the neurodegenerative cascade and pathogenesis of Alzheimer\u2019s disease. CNS Neurol Disorders-Drug Targets (Formerly Curr Drug Targets-CNS Neurol Disorders) 16:1050\u20131065","journal-title":"CNS Neurol Disorders-Drug Targets (Formerly Curr Drug Targets-CNS Neurol Disorders)"},{"key":"11047_CR23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41419-025-07609-w","volume":"16","author":"A Albini","year":"2025","unstructured":"Albini A, Di Paola L, Mei G et al (2025) Inflammation and cancer cell survival: TRAF2 as a key player. Cell Death Dis 16:292","journal-title":"Cell Death Dis"},{"key":"11047_CR24","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","volume":"2","author":"Y Xia","year":"2014","unstructured":"Xia Y, Shen S, Verma IM (2014) NF-\u03baB, an active player in human cancers. Cancer Immunol Res 2:823\u2013830","journal-title":"Cancer Immunol Res"},{"key":"11047_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07357907.2024.2437614","volume":"43","author":"G Kapoor","year":"2025","unstructured":"Kapoor G, Prakash S, Jaiswal V, Singh AK (2025) Chronic inflammation and cancer: key pathways and targeted therapies. Cancer Invest 43:1\u201323","journal-title":"Cancer Invest"},{"key":"11047_CR26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/path.4403","volume":"234","author":"J Messeguer","year":"2014","unstructured":"Messeguer J (2014) NF-\u03baB is required for VEGF expression and tumor angiogenesis. J Pathol 234:375\u2013385","journal-title":"J Pathol"},{"key":"11047_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2010.01.002","author":"F Li","year":"2010","unstructured":"Li F, Sethi G (2010) Targeting transcription factor NF-\u03baB to overcome chemoresistance and radioresistance in cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https:\/\/doi.org\/10.1016\/j.bbcan.2010.01.002","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"11047_CR28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.bbagrm.2010.05.004","volume":"1799","author":"SC Gupta","year":"2010","unstructured":"Gupta SC, Sundaram C, Reuter S, Aggarwal BB (2010) Inhibiting NF-\u03baB activation by small molecules as a therapeutic strategy. Biochim Biophys Acta 1799:775\u2013787","journal-title":"Biochim Biophys Acta"},{"key":"11047_CR29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12935-017-0413-y","volume":"17","author":"SM Cirigliano","year":"2017","unstructured":"Cirigliano SM, D\u00edaz Bessone MI, Berardi DE et al (2017) The synthetic peptide CIGB-300 modulates CK2-dependent signaling pathways affecting the survival and chemoresistance of non-small cell lung cancer cell lines. Cancer Cell Int 17:42","journal-title":"Cancer Cell Int"},{"key":"11047_CR30","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1186\/s12967-025-06583-3","volume":"23","author":"S Bakrim","year":"2025","unstructured":"Bakrim S, Fessikh ME, Elhrech H et al (2025) Targeting inflammation in cancer therapy: from mechanistic insights to emerging therapeutic approaches. J Transl Med 23:588","journal-title":"J Transl Med"},{"key":"11047_CR31","doi-asserted-by":"crossref","first-page":"1476030","DOI":"10.3389\/fimmu.2024.1476030","volume":"15","author":"Y Cao","year":"2024","unstructured":"Cao Y, Yi Y, Han C, Shi B (2024) NF-\u03baB signaling pathway in tumor microenvironment. Front Immunol 15:1476030","journal-title":"Front Immunol"},{"key":"11047_CR32","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12943-025-02379-7","volume":"24","author":"G Chen","year":"2025","unstructured":"Chen G, Chen B, Wu Y et al (2025) Bridging the tumor microenvironment: the pivotal role of cancer-associated fibroblasts in tumor cachexia development. Mol Cancer 24:194","journal-title":"Mol Cancer"},{"key":"11047_CR33","first-page":"172","volume":"271","author":"BB Aggarwal","year":"2011","unstructured":"Aggarwal BB, Sung B (2011) NF-\u03baB in cancer: a friend or foe? Cancer Lett 271:172\u2013178","journal-title":"Cancer Lett"},{"key":"11047_CR34","doi-asserted-by":"crossref","unstructured":"Karin M (2009) NF-\u03baB as a critical link between inflammation and cancer. Cold Spring Harbor perspectives in biology 1(5): p.a000141","DOI":"10.1101\/cshperspect.a000141"},{"key":"11047_CR35","first-page":"2241","volume":"53","author":"MY Lien","year":"2018","unstructured":"Lien MY (2018) Sodium butyrate inhibits proliferation and promotes apoptosis of colon cancer cells: involvement of NF-\u03baB. Int J Oncol 53:2241\u20132250","journal-title":"Int J Oncol"},{"key":"11047_CR36","unstructured":"Rana R (2022) Adrenergic signaling in cancer: therapeutic implications. Cancer Lett 536 :215660"},{"key":"11047_CR37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/1753425908091246","volume":"14","author":"H Loppnow","year":"2008","unstructured":"Loppnow H, Werdan K, Buerke M (2008) Invited review: vascular cells contribute to atherosclerosis by cytokine-and innate-immunity-related inflammatory mechanisms. Innate Immun 14:63\u201387","journal-title":"Innate Immun"},{"key":"11047_CR38","doi-asserted-by":"crossref","first-page":"564108","DOI":"10.3389\/fphar.2020.564108","volume":"11","author":"M Anuar","year":"2020","unstructured":"Anuar M, Hisam N, Liew NN, Ugusman NS (2020) Clinical review: Navitoclax as a pro-apoptotic and anti-fibrotic agent. Front Pharmacol 11:564108","journal-title":"Front Pharmacol"},{"key":"11047_CR39","volume":"4","author":"H Liu","year":"2024","unstructured":"Liu H, Yu Y, Dong A et al (2024) Emerging strategies for combating Fusobacterium nucleatum in colorectal cancer treatment: systematic review, improvements and future challenges. Exploration 4:20230092","journal-title":"Exploration"},{"issue":"20","key":"11047_CR40","doi-asserted-by":"crossref","first-page":"7777","DOI":"10.3390\/ijms21207777","volume":"21","author":"-D Colucci","year":"2020","unstructured":"Colucci -D, Amato L, Speranza L, Volpicelli F (2020) Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer. Int J Mol Sci 21(20):7777","journal-title":"Int J Mol Sci"},{"key":"11047_CR41","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117469","volume":"248","author":"J Chen","year":"2020","unstructured":"Chen J, Li N, Liu B et al (2020) Pracinostat (SB939), a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6\/STAT3 signalling pathways. Life Sci 248:117469","journal-title":"Life Sci"},{"key":"11047_CR42","unstructured":"Saldanha S (2014) Genetic And Epigenetic Changes Regulated By Bioactive Molecules In Cancer Therapeutics"},{"key":"11047_CR43","volume":"10","author":"Y Li","year":"2023","unstructured":"Li Y, Huang Y, Liang H et al (2023) The roles and applications of short-chain fatty acids derived from microbial fermentation of dietary fibers in human cancer. Front Nutr 10:1243390","journal-title":"Front Nutr"},{"key":"11047_CR44","unstructured":"Morgan P (2023) Investigating the role of adrenergic signalling in T-cell senescence (Doctoral dissertation)"},{"key":"11047_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0765-6","author":"MJ Park","year":"2016","unstructured":"Park MJ, Sohrabji F (2016) The histone deacetylase inhibitor, sodium butyrate, exhibits neuroprotective effects for ischemic stroke in middle-aged female rats. J Neuroinflammation. https:\/\/doi.org\/10.1186\/s12974-016-0765-6","journal-title":"J Neuroinflammation"},{"key":"11047_CR46","doi-asserted-by":"crossref","unstructured":"Sun, J., Lu, L., Lian, Y., Xu, S., Zhu, Y., Wu, Y., \u2026 Yu, Z. (2025). Sodium butyrate attenuates microglia-mediated neuroinflammation by modulating the TLR4\/MyD88\/NF-\u03baB pathway and microbiome-gut-brain axis in cardiac arrest mice. Molecular brain, 18(1), 1\u201323.","DOI":"10.1186\/s13041-025-01179-w"},{"key":"11047_CR47","volume":"184","author":"Y Li","year":"2024","unstructured":"Li Y, Liu A, Chen K et al (2024) Sodium butyrate alleviates lead-induced neuroinflammation and improves cognitive and memory impairment through the ACSS2\/H3K9ac\/BDNF pathway. Environ Int 184:108479","journal-title":"Environ Int"},{"issue":"3","key":"11047_CR48","doi-asserted-by":"crossref","first-page":"e1194","DOI":"10.1002\/iid3.1194","volume":"12","author":"Y Xu","year":"2024","unstructured":"Xu Y (2024) Sodium butyrate activates the K(ATP) channels to regulate microglia-mediated neuroinflammation induced by MPP\u2009+\u2009in a parkinson\u2019s disease model. Immun Inflamm Dis 12(3):e1194","journal-title":"Immun Inflamm Dis"},{"key":"11047_CR49","first-page":"3976","volume":"22","author":"S Zhang","year":"2018","unstructured":"Zhang S, Zhang Y (2018) Isoflurane reduces endotoxin-induced oxidative, inflammatory, and apoptotic responses in H9c2 cardiomyocytes. Eur Rev Med Pharmacol Sci 22:3976\u20133987","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"11047_CR50","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/cancers15020395","volume":"15","author":"M Barthelmess","year":"2023","unstructured":"Barthelmess M, Stijlemans R, Van Ginderachter B (2023) Hallmarks of cancer affected by the MIF cytokine family. Cancers 15:395","journal-title":"Cancers"},{"key":"11047_CR51","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2024.5632","author":"J Sun","year":"2024","unstructured":"Sun J, Chen S, Zang D et al (2024) Butyrate as a promising therapeutic target in cancer: from pathogenesis to clinic (Review). Int J Oncol. https:\/\/doi.org\/10.3892\/ijo.2024.5632","journal-title":"Int J Oncol"},{"key":"11047_CR52","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2174\/1871520622666220817125817","volume":"23","author":"J Qiu","year":"2023","unstructured":"Qiu J, Shen Z, Jiang G, Ni Q (2023) Isoproterenol-induced upregulation of HPSE accelerates triple-negative breast cancer cell proliferation and migration through enhancing the transcriptional activity of HIF-1\u03b1. Anticancer Agents Med Chem 23:470\u2013477","journal-title":"Anticancer Agents Med Chem"},{"key":"11047_CR53","volume":"48","author":"Y-J Kim","year":"2016","unstructured":"Kim Y-J, Kang Y, Park H-Y et al (2016) STEP signaling pathway mediates psychomotor stimulation and morphine withdrawal symptoms, but not for reward, analgesia and tolerance. Exp Mol Med 48:e212\u2013e212","journal-title":"Exp Mol Med"},{"key":"11047_CR54","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/0360-3016(82)90459-X","volume":"8","author":"GW Barendsen","year":"1982","unstructured":"Barendsen GW (1982) Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 8:1981\u20131997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11047_CR55","volume":"84","author":"Y Li","year":"2020","unstructured":"Li Y, Feng L, Li G et al (2020) Resveratrol prevents ISO-induced myocardial remodeling associated with regulating polarization of macrophages through VEGF-B\/AMPK\/NF-kB pathway. Int Immunopharmacol 84:106508","journal-title":"Int Immunopharmacol"},{"key":"11047_CR56","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1038\/onc.2015.337","volume":"35","author":"S Seoane","year":"2016","unstructured":"Seoane S, Montero JC, Oca\u00f1a A, Pandiella A (2016) Breast cancer dissemination promoted by a neuregulin-collagenase 3 signalling node. Oncogene 35:2756\u20132765","journal-title":"Oncogene"},{"key":"11047_CR57","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3390\/antiox14050579","volume":"14","author":"A From Guo","year":"2025","unstructured":"From Guo A, Liu Z, Hou S (2025) Isorhamnetin attenuates isoproterenol-induced myocardial injury by reducing ENO1 (alpha-enolase) in cardiomyocytes. Antioxidants 14:579","journal-title":"Antioxidants"},{"key":"11047_CR58","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.115767","volume":"228","author":"R Gupta","year":"2023","unstructured":"Gupta R, Kadhim MM, Turki Jalil A et al (2023) Multifaceted role of NF-\u03baB in hepatocellular carcinoma therapy: molecular landscape, therapeutic compounds and nanomaterial approaches. Environ Res 228:115767","journal-title":"Environ Res"},{"key":"11047_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14050579","author":"Z Guo","year":"2025","unstructured":"Guo Z, Liu S, Hou X et al (2025) Isorhamnetin attenuates isoproterenol-induced myocardial injury by reducing ENO1 (alpha-enolase) in cardiomyocytes. Antioxidants. https:\/\/doi.org\/10.3390\/antiox14050579","journal-title":"Antioxidants"},{"key":"11047_CR60","doi-asserted-by":"crossref","first-page":"W478","DOI":"10.1093\/nar\/gku377","volume":"42","author":"CC Huang","year":"2014","unstructured":"Huang CC, Meng EC, Morris JH et al (2014) Enhancing UCSF chimera through web services. Nucleic Acids Res 42:W478\u2013W484","journal-title":"Nucleic Acids Res"},{"key":"11047_CR61","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W et al (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791","journal-title":"J Comput Chem"},{"key":"11047_CR62","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.1c00203","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S (2021) Autodock Vina 1.2. 0: new docking methods, expanded force field, and python bindings. J Chem Inf Modeling 61(8): 3891-3898 https:\/\/doi.org\/10.1021\/acs.jcim.1c00203","journal-title":"J Chem Inf Model"},{"key":"11047_CR63","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","volume":"1263","author":"S Dallakyan","year":"2015","unstructured":"Dallakyan S, Olson AJ (2015) Small-molecule library screening by docking with pyrx. Methods Mol Biol 1263:243\u2013250","journal-title":"Methods Mol Biol"},{"key":"11047_CR64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1868-7083-4-1","volume":"4","author":"B Canani","year":"2012","unstructured":"Canani B, Di Costanzo R, Leone M (2012) The epigenetic effects of butyrate: potential therapeutic implications for clinical practice. Clin Epigenetics 4:1\u20137","journal-title":"Clin Epigenetics"},{"issue":"5","key":"11047_CR65","doi-asserted-by":"crossref","DOI":"10.3390\/cells12050788","volume":"12","author":"K Deka","year":"2023","unstructured":"Deka K, Li Y (2023) Transcriptional regulation during aberrant activation of NF-\u03baB signalling in cancer. Cells 12(5):788","journal-title":"Cells"},{"key":"11047_CR66","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.celrep.2012.08.042","volume":"2","author":"VY-F Wang","year":"2012","unstructured":"Wang VY-F, Huang W, Asagiri M et al (2012) The transcriptional specificity of NF-\u03baB dimers is coded within the \u03baB DNA response elements. Cell Rep 2:824\u2013839","journal-title":"Cell Rep"},{"key":"11047_CR67","doi-asserted-by":"crossref","first-page":"a000034","DOI":"10.1101\/cshperspect.a000034","volume":"1","author":"A Oeckinghaus","year":"2009","unstructured":"Oeckinghaus A, Ghosh S (2009) The NF- B family of transcription factors and its regulation. Cold Spring Harb Perspect Biol 1:a000034\u2013a000034","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"11047_CR68","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S1567-5769(02)00058-9","volume":"2","author":"T Wang","year":"2002","unstructured":"Wang T, Zhang X, Li JJ (2002) The role of NF-\u03baB in the regulation of cell stress responses. Int Immunopharmacol 2:1509\u20131520","journal-title":"Int Immunopharmacol"},{"key":"11047_CR69","first-page":"368","volume":"2","author":"M Serasanambati","year":"2016","unstructured":"Serasanambati M, Chilakapati SR (2016) Function of nuclear factor kappa B (NF-kB) in human diseases-a review. S Ind J Biol Sci 2:368","journal-title":"S Ind J Biol Sci"},{"key":"11047_CR70","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1042\/BST20130156","volume":"42","author":"AC Ledoux","year":"2014","unstructured":"Ledoux AC, Perkins ND (2014) NF-\u03bab and the cell cycle. Biochem Soc Trans 42:76\u201381","journal-title":"Biochem Soc Trans"},{"key":"11047_CR71","first-page":"569","volume":"35","author":"JA Quinn","year":"2020","unstructured":"Quinn JA, Bennett L, Patel M et al (2020) The relationship between members of the canonical NF-kB pathway, tumour microenvironment and cancer specific survival in colorectal cancer patients. Histol Histopathol 35:569\u2013578","journal-title":"Histol Histopathol"},{"key":"11047_CR72","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13075-015-0527-3","volume":"17","author":"AR Noort","year":"2015","unstructured":"Noort AR, Tak PP, Tas SW (2015) Non-canonical NF-\u03baB signaling in rheumatoid arthritis: Dr jekyll and Mr hyde? Arthritis Res Ther 17:15","journal-title":"Arthritis Res Ther"},{"key":"11047_CR73","doi-asserted-by":"crossref","first-page":"104564","DOI":"10.1016\/j.biosystems.2021.104564","volume":"211","author":"K Trares","year":"2022","unstructured":"Trares K, Ackermann J, Koch I (2022) The canonical and non-canonical NF-\u03baB pathways and their crosstalk: a comparative study based on petri nets. Biosystems 211:104564","journal-title":"Biosystems"},{"key":"11047_CR74","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2020.579674","volume":"7","author":"L Jiang","year":"2020","unstructured":"Jiang L, Wang J, Liu Z et al (2020) Sodium butyrate alleviates lipopolysaccharide-induced inflammatory responses by down-regulation of NF-\u03baB, NLRP3 signaling pathway, and activating histone acetylation in bovine macrophages. Front Vet Sci 7:579674","journal-title":"Front Vet Sci"},{"key":"11047_CR75","volume":"38","author":"S Cavalu","year":"2024","unstructured":"Cavalu S, Saber S, Amer AE et al (2024) The multifaceted role of beta-blockers in overcoming cancer progression and drug resistance: extending beyond cardiovascular disorders. FASEB J 38:e23813","journal-title":"FASEB J"},{"key":"11047_CR76","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41419-023-05645-y","volume":"14","author":"M Tan","year":"2023","unstructured":"Tan M, Yin Y, Ma X et al (2023) Glutathione system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis. Cell Death Dis 14:131","journal-title":"Cell Death Dis"},{"key":"11047_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.708093","author":"Y Li","year":"2021","unstructured":"Li Y, He P, Liu Y et al (2021) Combining sodium butyrate with cisplatin increases the apoptosis of gastric cancer in vivo and in vitro via the mitochondrial apoptosis pathway. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.708093","journal-title":"Front Pharmacol"},{"key":"11047_CR78","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.924192","volume":"9","author":"AI Mahmod","year":"2022","unstructured":"Mahmod AI, Haif SK, Kamal A et al (2022) Chemoprevention effect of the mediterranean diet on colorectal cancer: current studies and future prospects. Front Nutr 9:924192","journal-title":"Front Nutr"},{"key":"11047_CR79","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.3748\/wjg.v30.i14.2018","volume":"30","author":"Q-L Wu","year":"2024","unstructured":"Wu Q-L, Fang X-T, Wan X-X et al (2024) Fusobacterium nucleatum-induced imbalance in microbiome-derived butyric acid levels promotes the occurrence and development of colorectal cancer. World J Gastroenterol 30:2018\u20132037","journal-title":"World J Gastroenterol"},{"key":"11047_CR80","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.euroneuro.2007.11.004","volume":"18","author":"SI Deutsch","year":"2008","unstructured":"Deutsch SI, Rosse RB, Long KD et al (2008) Sodium butyrate, an epigenetic interventional strategy, attenuates a stress-induced alteration of MK-801\u2019s pharmacologic action. Eur Neuropsychopharmacol 18:565\u2013568","journal-title":"Eur Neuropsychopharmacol"},{"key":"11047_CR81","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/07357907.2022.2055050","volume":"40","author":"D Pouya","year":"2022","unstructured":"Pouya D, Rasmi F, Nemati Y (2022) Signaling pathways involved in 5-FU drug resistance in cancer. Cancer Invest 40:516\u2013543","journal-title":"Cancer Invest"},{"key":"11047_CR82","first-page":"3","volume-title":"Advances in experimental medicine and biology","author":"B Weinstein","year":"2008","unstructured":"Weinstein B (2008) Relevance of the concept of oncogene addiction to hormonal carcinogenesis and molecular targeting in cancer prevention and therapy. In J. J. Li, S. A. Li, S. Mohla, H. Rochefort, & T. Maudelonde (Eds.), Advances in experimental medicine and biology. Springer New York, New York, NY, 617: pp 3\u201313"},{"key":"11047_CR83","doi-asserted-by":"publisher","unstructured":"Xie T, Zhang S (2024) Inhibition of NF-\u03baB signaling unveils novel strategies to overcome drug resistance in cancer. Cancer Lett 599. https:\/\/doi.org\/10.1016\/j.canlet.2023.216676","DOI":"10.1016\/j.canlet.2023.216676"},{"key":"11047_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031572","author":"N Kim","year":"2024","unstructured":"Kim N, Yang C (2024) Sodium butyrate inhibits the expression of thymidylate synthase and induces cell death in colorectal cancer cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25031572","journal-title":"Int J Mol Sci"},{"key":"11047_CR85","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12012-011-9111-5","volume":"11","author":"AF Branco","year":"2011","unstructured":"Branco AF, Pereira SL, Moreira AC et al (2011) Isoproterenol cytotoxicity is dependent on the differentiation state of the cardiomyoblast H9c2 cell line. Cardiovasc Toxicol 11:191\u2013203","journal-title":"Cardiovasc Toxicol"},{"key":"11047_CR86","first-page":"2497","volume":"27","author":"S Jackson","year":"2021","unstructured":"Jackson S (2021) NF-\u03baB signaling and cancer progression: therapeutic perspective. Clin Cancer Res 27:2497\u20132503","journal-title":"Clin Cancer Res"},{"key":"11047_CR87","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ijc.2910550329","volume":"55","author":"A Hague","year":"1993","unstructured":"Hague A, Manning AM, Hanlon KA et al (1993) Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large\u2010bowel cancer. Int J Cancer 55:498\u2013505","journal-title":"Int J Cancer"},{"key":"11047_CR88","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/aps.2017.58","volume":"39","author":"H-Q Hong","year":"2018","unstructured":"Hong H-Q, Lu J, Fang X-L et al (2018) G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-\u03baB signaling pathway. Acta Pharmacol Sin 39:184\u2013194","journal-title":"Acta Pharmacol Sin"},{"key":"11047_CR89","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00432-016-2278-1","volume":"143","author":"M Coelho","year":"2017","unstructured":"Coelho M, Soares-Silva C, Brand\u00e3o D et al (2017) \u0392-adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives. J Cancer Res Clin Oncol 143:275\u2013291","journal-title":"J Cancer Res Clin Oncol"},{"key":"11047_CR90","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd4579","volume":"14","author":"KJ Falkenberg","year":"2015","unstructured":"Falkenberg KJ, Johnstone RW (2015) Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat Rev Drug Discov 14:219\u2013219","journal-title":"Nat Rev Drug Discov"},{"key":"11047_CR91","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/1078-0432.CCR-11-0641","volume":"18","author":"SW Cole","year":"2012","unstructured":"Cole SW, Sood AK (2012) Molecular pathways: beta-adrenergic signaling in cancer. Clin Cancer Res 18:1201\u20131206","journal-title":"Clin Cancer Res"},{"key":"11047_CR92","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, Furumichi M, Tanabe M et al (2017) KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 45:D353\u2013D361","journal-title":"Nucleic Acids Res"},{"key":"11047_CR93","first-page":"146","volume":"8","author":"VT Cunliffe","year":"2008","unstructured":"Cunliffe VT (2008) ChIP-seq: a powerful tool for understanding transcription regulation. Briefings Funct Genomics Proteomics 8:146\u2013154","journal-title":"Briefings Funct Genomics Proteomics"},{"key":"11047_CR94","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nrm1857","volume":"7","author":"AR Joyce","year":"2006","unstructured":"Joyce AR, Palsson BO (2006) The model organism as a system: integrating omics data sets. Nat Rev Mol Cell Biol 7:198\u2013210","journal-title":"Nat Rev Mol Cell Biol"},{"key":"11047_CR95","unstructured":"Sengupta S, Kundu S, Roy A, Chattopadhyay U (2021) Targeting tumor microenvironment in breast and colorectal cancer via epigenetic and inflammatory pathways: potential role of HDAC inhibitors and adrenergic modulators. Frontiers in Oncology11:678333."},{"key":"11047_CR96","first-page":"3156","volume":"33","author":"RL Eckert","year":"2013","unstructured":"Eckert RL (2013) Pharmacological aspects of histone deacetylase inhibitors. Mol Cell Biol 33:3156\u20133164","journal-title":"Mol Cell Biol"},{"key":"11047_CR97","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/cr.2011.13","volume":"21","author":"MS Hayden","year":"2011","unstructured":"Hayden MS, Ghosh S (2011) NF-\u03baB in immunobiology. Cell Res 21:223\u2013244","journal-title":"Cell Res"},{"key":"11047_CR98","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10125","volume":"4","author":"AC Anselmo","year":"2019","unstructured":"Anselmo AC, Mitragotri S (2019) Nanoparticles in the clinic: an update. Bioeng Transl Med 4:e10143","journal-title":"Bioeng Transl Med"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11047-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11047-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11047-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T05:05:15Z","timestamp":1766898315000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11047-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11047"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11047-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,22]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"938"}}